Castle Biosciences (CSTL) Other Non Operating Income (2018 - 2026)
Castle Biosciences (CSTL) posted Other Non Operating Income of -$153000.0 for Q2 2026, up 65.15% sequentially from -$439000.0 in Q1 2026.
Castle Biosciences (CSTL) Other Non Operating Income (2018 - 2026) Analysis & Trends
Castle Biosciences has reported Other Non Operating Income for 5 years, with the latest figure at -$153000.0 in Q2 2026.
- Quarterly Other Non Operating Income changed N/A year-over-year to -$153000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$448000.0 (changed N/A YoY) and the FY2025 annual result came in at $144000.0, changed N/A from the prior year.
- Other Non Operating Income advanced to -$153000.0 in Q2 2026 per CSTL's latest filing, from -$439000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $96000.0 in Q4 2025 and troughed at -$439000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Castle Biosciences | 1.04 Bn | 773.13 Mn | 79.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -153,000.00 |
| Mar 31, 2026 | -439,000.00 |
| Dec 31, 2025 | 96,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Dec 31, 2020 | -1.40 Mn |
| Dec 31, 2019 | 235,000.00 |
| Sep 30, 2019 | 5.20 Mn |
| Jun 30, 2019 | -189,000.00 |
| Mar 31, 2019 | -33,000.00 |
| Dec 31, 2018 | -242,544.00 |
| Sep 30, 2018 | -42,796.00 |
| Jun 30, 2018 | 34,038.00 |